405 related articles for article (PubMed ID: 33360047)
21. Metformin: old friend, new ways of action-implication of the gut microbiome?
Rodriguez J; Hiel S; Delzenne NM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
[TBL] [Abstract][Full Text] [Related]
22. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults.
Hibberd AA; Yde CC; Ziegler ML; Honoré AH; Saarinen MT; Lahtinen S; Stahl B; Jensen HM; Stenman LK
Benef Microbes; 2019 Mar; 10(2):121-135. PubMed ID: 30525950
[TBL] [Abstract][Full Text] [Related]
23. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Wu H; Esteve E; Tremaroli V; Khan MT; Caesar R; Mannerås-Holm L; Ståhlman M; Olsson LM; Serino M; Planas-Fèlix M; Xifra G; Mercader JM; Torrents D; Burcelin R; Ricart W; Perkins R; Fernàndez-Real JM; Bäckhed F
Nat Med; 2017 Jul; 23(7):850-858. PubMed ID: 28530702
[TBL] [Abstract][Full Text] [Related]
24. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial.
Ho J; Reimer RA; Doulla M; Huang C
Trials; 2016 Jul; 17(1):347. PubMed ID: 27456494
[TBL] [Abstract][Full Text] [Related]
25. Effects of synbiotic supplementation on intestinal microbiota composition in children and adolescents with exogenous obesity: (Probesity-2 trial).
Kilic Yildirim G; Dinleyici M; Vandenplas Y; Dinleyici EC
Gut Pathog; 2023 Jul; 15(1):36. PubMed ID: 37474971
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger.
McDonagh MS; Selph S; Ozpinar A; Foley C
JAMA Pediatr; 2014 Feb; 168(2):178-84. PubMed ID: 24343296
[TBL] [Abstract][Full Text] [Related]
27. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
28. Metagenomics study on taxonomic and functional change of gut microbiota in patients with obesity with PCOS treated with exenatide combination with metformin or metformin alone.
Gan J; Chen J; Ma RL; Deng Y; Ding XS; Zhu SY; Sun AJ
Gynecol Endocrinol; 2023 Dec; 39(1):2219342. PubMed ID: 37290480
[TBL] [Abstract][Full Text] [Related]
29. Common Variants in 22 Genes Regulate Response to Metformin Intervention in Children with Obesity: A Pharmacogenetic Study of a Randomized Controlled Trial.
Anguita-Ruiz A; Pastor-Villaescusa B; Leis R; Bueno G; Hoyos R; Vázquez-Cobela R; Latorre-Millán M; Cañete MD; Caballero-Villarraso J; Gil Á; Cañete R; Aguilera CM
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31527397
[TBL] [Abstract][Full Text] [Related]
30. Effects of Conjugated Linoleic Acid and Metformin on Insulin Sensitivity in Obese Children: Randomized Clinical Trial.
Garibay-Nieto N; Queipo-García G; Alvarez F; Bustos M; Villanueva E; Ramírez F; León M; Laresgoiti-Servitje E; Duggirala R; Macías T; Cuevas S; Jalife A; Fonseca-Sánchez M; Serratos F; López-Alvarenga JC
J Clin Endocrinol Metab; 2017 Jan; 102(1):132-140. PubMed ID: 27778642
[TBL] [Abstract][Full Text] [Related]
31. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
[TBL] [Abstract][Full Text] [Related]
32. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C
Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
[TBL] [Abstract][Full Text] [Related]
34. Metformin in obese children and adolescents: the MOCA trial.
Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
[TBL] [Abstract][Full Text] [Related]
35. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
mBio; 2018 May; 9(3):. PubMed ID: 29789365
[TBL] [Abstract][Full Text] [Related]
36. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
[TBL] [Abstract][Full Text] [Related]
37. Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
Rutten NB; Gorissen DM; Eck A; Niers LE; Vlieger AM; Besseling-van der Vaart I; Budding AE; Savelkoul PH; van der Ent CK; Rijkers GT
PLoS One; 2015; 10(9):e0137681. PubMed ID: 26378926
[TBL] [Abstract][Full Text] [Related]
38. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance.
Love-Osborne K; Sheeder J; Zeitler P
J Pediatr; 2008 Jun; 152(6):817-22. PubMed ID: 18492523
[TBL] [Abstract][Full Text] [Related]
39. Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial.
Solito A; Bozzi Cionci N; Calgaro M; Caputo M; Vannini L; Hasballa I; Archero F; Giglione E; Ricotti R; Walker GE; Petri A; Agosti E; Bellomo G; Aimaretti G; Bona G; Bellone S; Amoruso A; Pane M; Di Gioia D; Vitulo N; Prodam F
Clin Nutr; 2021 Jul; 40(7):4585-4594. PubMed ID: 34229263
[TBL] [Abstract][Full Text] [Related]
40. Environmental and intrinsic factors shaping gut microbiota composition and diversity and its relation to metabolic health in children and early adolescents: A population-based study.
Moran-Ramos S; Lopez-Contreras BE; Villarruel-Vazquez R; Ocampo-Medina E; Macias-Kauffer L; Martinez-Medina JN; Villamil-Ramirez H; León-Mimila P; Del Rio-Navarro BE; Ibarra-Gonzalez I; Vela-Amieva M; Gomez-Perez FJ; Velazquez-Cruz R; Salmeron J; Reyes-Castillo Z; Aguilar-Salinas C; Canizales-Quinteros S
Gut Microbes; 2020 Jul; 11(4):900-917. PubMed ID: 31973685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
